Chronic peripheral administration of the angiotensin II AT1 receptor antagonist Candesartan blocks brain AT1 receptors
- 5 July 2000
- journal article
- Published by Elsevier in Brain Research
- Vol. 871 (1) , 29-38
- https://doi.org/10.1016/s0006-8993(00)02377-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Inhibition of the Angiotensin II Type 1 Receptor by TCV-116: Quantitation by In Vitro AutoradiographyThe Japanese Journal of Pharmacology, 1999
- Losartan inhibition of angiotensin-related drinking and Fos immunoreactivity in hypertensive and hypotensive contextsBrain Research, 1996
- Functional evidence for the ability of angiotensin AT1 receptor antagonists to cross the blood-brain barrier in ratsEuropean Journal of Pharmacology, 1996
- AT1A, AT1B, and AT2angiotensin II receptor subtype gene expression in rat brainNeuroReport, 1995
- BLOCKADE BY INTRAVENOUS LOSARTAN OF AT1 ANGIOTENSIN II RECEPTORS IN RAT BRAIN, KIDNEY AND ADRENALS DEMONSTRATED BY IN VITRO AUTORADIOGRAPHYClinical and Experimental Pharmacology and Physiology, 1994
- Characterization of brain angiotensin II AT2 receptor subtype using [125I] CGP 42112ANeuroReport, 1993
- Losartan potassium, a nonpeptide antagonist of angiotensin II, chronically administered p.o. does not readily cross the blood-brain barrierEuropean Journal of Pharmacology, 1992
- Isolation of a cDNA encoding the vascular type-1 angiotensin II receptorNature, 1991
- Calibration of 125I-polymer standards with 125I-brain paste standards for use in quantitative receptor autoradiographyJournal of Neuroscience Methods, 1989
- Angiotensin II binding sites in the anteroventral-third ventricle (AV3V) area and related structures of the rat brainNeuroscience Letters, 1986